Transglutaminase-2 is Involved in Cell Apoptosis of Osteosarcoma Cell Line U2OS Under Hypoxia Condition
Authors:
- 6 January 2015
- journal article
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 72 (1) , 283-288
Abstract
Osteosarcoma is the most common type of solid bone cancer, which is the second leading cause of cancer-related death. Hypoxia is an ordinary phenomenon in solid tumor tissues and can induce cell apoptosis but the specific molecular mechanism remains unclear. In this study, we explored the effect and the molecular mechanism of Transglutaminase 2 (TG2) on cell apoptosis in osteosarcoma U2OS cells under hypoxia. We found the enzymatic activity of TG2 is significantly increased and the expression of TG2 is remarkably up-regulated under hypoxia condition. Cell apoptotic rate is markedly increased upon knockdown of TG2 by siRNA under hypoxia. We further investigated the mechanism of cell apoptosis and found Bax protein is significantly increased after depletion of TG2 under hypoxia. Moreover, our data also show that cytochrome C (Cyt C) is significantly increased in cytoplasm and markedly decreased in mitochondria of U2OS cells after depletion of TG2 under hypoxia. Our results suggest that TG2 can inhibit tumor cell apoptosis through down-regulation of Bax and prevention of release Cyt C from mitochondria into cytoplasm.Keywords
This publication has 19 references indexed in Scilit:
- Hypoxic Tumor Environments Exhibit Disrupted Collagen I Fibers and Low Macromolecular TransportPLOS ONE, 2013
- Transglutaminase 2 Contributes to Apoptosis Induction in Jurkat T Cells by Modulating Ca2+ Homeostasis via Cross-Linking RAP1GDS1PLOS ONE, 2013
- Transglutaminase-Catalyzed Protein-Protein Cross-Linking Suppresses the Activity of the NF-κB–Like Transcription Factor RelishScience Signaling, 2013
- Silencing of Pokemon Enhances Caspase-Dependent Apoptosis via Fas- and Mitochondria-Mediated Pathways in Hepatocellular Carcinoma CellsPLOS ONE, 2013
- Transglutaminase-2 Is Involved in Expression of Osteoprotegerin in MG-63 Osteosarcoma CellsBiomolecules & Therapeutics, 2013
- Transglutaminase 2 cross-linking activity is linked to invadopodia formation and cartilage breakdown in arthritisArthritis Research & Therapy, 2012
- Phosphorylation of transglutaminase 2 (TG2) at serine-216 has a role in TG2 mediated activation of nuclear factor-kappa B and in the downregulation of PTENBMC Cancer, 2012
- Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?European Journal of Cancer, 2011
- Targeting the osteosarcoma cancer stem cellJournal of Orthopaedic Surgery and Research, 2010
- Hypoxia signalling in cancer and approaches to enforce tumour regressionNature, 2006